Stora Enso to establish a joint pulp mill biorefinery research and development project with Metso and Domtar
Stora Enso has signed a research and development cooperation agreement with
Metso and Domtar to establish a consortium to develop a pulp mill biorefinery.
The project, based on the latest pulping technology, aims to develop a pulp
production process with enhanced sustainability and cost efficiency, as well as
lower investment costs.
“We see promising opportunities for a breakthrough in sustainable chemical
pulping technology. The new major innovations will give stronger fibre and
improve the pulping yield. The innovations will also enable malodorous gases to
be eliminated and increase the energy efficiency of the pulp production
process,” says Jukka Kilpeläinen, Senior Vice President, Group R&D.
For further information, please contact:
Jukka Kilpeläinen, Senior Vice President, Group R&D, tel. +358 2046 21277
Päivi Kauhanen, Director, Communications in Finland, tel. +358 2046 21292
www.storaenso.com
www.storaenso.com/investors
Metso is a global supplier of sustainable technology and services for mining,
construction, power generation, automation, recycling and the pulp and paper
industries. Metso has about 27 000 employees in more than 50 countries.
Domtar Corporation is the largest integrated manufacturer and marketer of
uncoated freesheet paper in North America and the second largest in the world.
Domtar also manufactures paper grade, fluff and specialty pulp.
Stora Enso is the world leader in forest industry sustainability. We offer our
customers solutions based on renewable raw materials. Our products provide a
climate-friendly alternative to many non-renewable materials, and have a smaller
carbon footprint. Stora Enso is listed in the Dow Jones Sustainability Index and
the FTSE4Good Index. Stora Enso employs some 27 000 people worldwide, and our
sales in 2009 amounted to EUR 8.9 billion. Stora Enso shares are listed on
NASDAQ OMX Helsinki (STEAV, STERV) and Stockholm (STE A, STE R). In addition,
the shares are traded in the USA as ADRs (SEOAY) in the International OTCQX
over-the-counter market.